Journal article
Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study
Abstract
OBJECTIVE: Mycophenolate mofetil (MMF), along with corticosteroids, is considered as the standard of care in lupus nephritis (LN); however, little is known regarding its efficacy in extrarenal manifestations of systemic lupus erythematosus (SLE). We aimed to determine its effectiveness in nonrenal SLE.
METHODS: One hundred seventy-seven patients with SLE were enrolled; 105 for whom MMF was introduced for active LN (mean age 35.6 ± 10.7 yrs, …
Authors
Tselios K; Gladman DD; Su J; Urowitz MB
Journal
The Journal of Rheumatology, Vol. 43, No. 3, pp. 552–558
Publisher
The Journal of Rheumatology
Publication Date
March 2016
DOI
10.3899/jrheum.150779
ISSN
0315-162X